Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 13, 2008
Diabetes 57:1536-1543, 2008
DOI: 10.2337/db08-0094
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db08-0094v1
57/6/1536    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomlinson, J. W.
Right arrow Articles by Stewart, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomlinson, J. W.
Right arrow Articles by Stewart, P. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Reduced Glucocorticoid Production Rate, Decreased 5{alpha}-Reductase Activity, and Adipose Tissue Insulin Sensitization After Weight Loss

Jeremy W. Tomlinson1, Joanne Finney2, Beverly A. Hughes1, Susan V. Hughes1, and Paul M. Stewart1

1 Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, U.K
2 Wellcome Trust Clinical Research Facility, University Hospitals Birmingham National Health Service Foundation Trust, Birmingham, U.K

Corresponding author: Dr. Jeremy W. Tomlinson, PhD, MRCP, Institute of Biomedical Research, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham, U.K. B15 2TT. E-mail: j.w.tomlinson{at}bham.ac.uk

Key Words: 5{alpha}R, 5{alpha}-reductase • 5βR, 5β-reductase • 11β-HSD1, 11β-hydroxysteroid dehydrogenase type 1 • AUC, area under the curve • DEXA, dual-energy X-ray absorptiometry • HPA, hypothalamo-pituitary-adrenal • RIA, radioimmunoassay • THE, tetrahydrocortisone • THF, tetrahydrocortisol • VLCD, very low–calorie diet

OBJECTIVE—The epidemics of obesity, insulin resistance, and type 2 diabetes have heightened the need to understand mechanisms that contribute to their pathogenesis. Increased endogenous glucocorticoid production has been implicated based on parallels with Cushing's syndrome. We have assessed the impact of weight loss on glucocorticoid secretion and metabolism (notably 11β-hydroxysteroid dehydrogenase type 1 and 5{alpha}-reductase [5{alpha}R] activity) and insulin sensitivity.

RESEARCH DESIGN AND METHODS—Twenty obese volunteers were investigated before and after weight loss. Patients underwent hyperinsulinemic-euglycemic clamps with simultaneous adipose microdialysis and oral cortisone acetate administration. Changes in glucocorticoid secretion and metabolism were assessed using 24-h urine collections.

RESULTS—Before weight loss, fat mass correlated with glucocorticoid secretion rate (total fat, r = 0.46, P < 0.05; trunk fat, r = 0.52, P < 0.05); however, glucocorticoid secretion rate was inversely related to insulin sensitivity (r = –0.51, P < 0.05). Hyperinsulinemia failed to suppress adipose tissue interstitial fluid glycerol release (180 ± 50 µmol [basal] vs. 153 ± 10 µmol [steady state], NS). After oral cortisone (25 mg), cortisol concentrations within adipose interstitial fluid increased (4.3 ± 1.1 vs. 14.2 ± 2.6 nmol/l, P < 0.01), but glycerol concentrations did not change. After weight loss, insulin sensitivity increased. Consistent with insulin sensitization, adipose tissue interstitial fluid glycerol concentrations fell under hyperinsulinemic conditions (186 ± 16 vs. 117 ± 9 µmol, P < 0.05). Glucocorticoid secretion decreased (11,751 ± 1,520 vs. 7,464 ± 937 µg/24 h, P < 0.05) as did 5{alpha}R activity (5{alpha}-tetrahydrocortisol–to–tetrahydrocortisol ratio 1.41 ± 0.16 vs. 1.12 ± 0.17, P < 0.005).

CONCLUSIONS—Obesity is associated with insulin resistance within adipose tissue and increased cortisol secretion rates; both are reversed with weight loss. Reduced 5{alpha}R activity after weight loss may decrease hypothalamo-pituitary-adrenal axis activation and reduce glucocorticoid metabolite production.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. W. Tomlinson, J. Finney, C. Gay, B. A. Hughes, S. V. Hughes, and P. M. Stewart
Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5{alpha}-Reductase Activity
Diabetes, October 1, 2008; 57(10): 2652 - 2660.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.